Ligand Pharmaceuticals | LGND - PE Price to Earnings


Ligand Pharmaceuticals reported $60.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen USD 9.49 3.02 Sep/2025
Baxter International USD 17.1 4.46 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ligand Pharmaceuticals USD 60.65 17.62 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Veracyte USD 50.7 8.04 Sep/2025